Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1956 1
1957 4
1958 2
1960 3
1961 4
1962 3
1963 5
1964 9
1965 6
1966 6
1967 22
1968 16
1969 15
1970 18
1971 18
1972 11
1973 15
1974 16
1975 20
1976 14
1977 33
1978 36
1979 31
1980 44
1981 42
1982 50
1983 73
1984 60
1985 68
1986 64
1987 81
1988 112
1989 132
1990 141
1991 123
1992 118
1993 125
1994 149
1995 140
1996 155
1997 157
1998 176
1999 222
2000 203
2001 210
2002 240
2003 217
2004 243
2005 216
2006 242
2007 250
2008 268
2009 267
2010 308
2011 319
2012 320
2013 338
2014 342
2015 288
2016 310
2017 369
2018 400
2019 440
2020 478
2021 175
Text availability
Article attribute
Article type
Publication date

Search Results

8,288 results
Results by year
Filters applied: . Clear all
Page 1
A lipidome atlas in MS-DIAL 4.
Tsugawa H, Ikeda K, Takahashi M, Satoh A, Mori Y, Uchino H, Okahashi N, Yamada Y, Tada I, Bonini P, Higashi Y, Okazaki Y, Zhou Z, Zhu ZJ, Koelmel J, Cajka T, Fiehn O, Saito K, Arita M, Arita M. Tsugawa H, et al. Among authors: yamada y. Nat Biotechnol. 2020 Oct;38(10):1159-1163. doi: 10.1038/s41587-020-0531-2. Epub 2020 Jun 15. Nat Biotechnol. 2020. PMID: 32541957
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, Yamada Y, Nagano T, Morishima E, Matsuda N; J-Land 3S Study Group. Kakihana Y, et al. Among authors: yamada y. Lancet Respir Med. 2020 Sep;8(9):863-872. doi: 10.1016/S2213-2600(20)30037-0. Epub 2020 Mar 31. Lancet Respir Med. 2020. PMID: 32243865 Clinical Trial.
Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases: A Review.
Glicksman RM, Tjong MC, Neves-Junior WFP, Spratt DE, Chua KLM, Mansouri A, Chua MLK, Berlin A, Winter JD, Dahele M, Slotman BJ, Bilsky M, Shultz DB, Maldaun M, Szerlip N, Lo SS, Yamada Y, Vera-Badillo FE, Marta GN, Moraes FY. Glicksman RM, et al. Among authors: yamada y. JAMA Oncol. 2020 Apr 1;6(4):567-577. doi: 10.1001/jamaoncol.2019.5351. JAMA Oncol. 2020. PMID: 31895403 Review.
Generation of a p16 Reporter Mouse and Its Use to Characterize and Target p16high Cells In Vivo.
Omori S, Wang TW, Johmura Y, Kanai T, Nakano Y, Kido T, Susaki EA, Nakajima T, Shichino S, Ueha S, Ozawa M, Yokote K, Kumamoto S, Nishiyama A, Sakamoto T, Yamaguchi K, Hatakeyama S, Shimizu E, Katayama K, Yamada Y, Yamazaki S, Iwasaki K, Miyoshi C, Funato H, Yanagisawa M, Ueno H, Imoto S, Furukawa Y, Yoshida N, Matsushima K, Ueda HR, Miyajima A, Nakanishi M. Omori S, et al. Among authors: yamada y. Cell Metab. 2020 Nov 3;32(5):814-828.e6. doi: 10.1016/j.cmet.2020.09.006. Epub 2020 Sep 18. Cell Metab. 2020. PMID: 32949498
Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical Practice.
Yamada Y, Tamura T, Yamamoto Y, Ichimura H, Hayashihara K, Saito T, Yamada H, Endo T, Nakamura R, Inage Y, Satoh H, Iguchi K, Saito K, Inagaki M, Kikuchi N, Kurishima K, Ishikawa H, Sakai M, Kamiyama K, Shiozawa T, Hizawa N, Sekine I, Sato Y, Funayama Y, Miyazaki K, Kodama T, Hayashi S, Nomura A, Nakamura H, Furukawa K, Yamashita T, Okubo H, Suzuki H, Kiyoshima M, Kaburagi T. Yamada Y, et al. Anticancer Res. 2020 Oct;40(10):5757-5764. doi: 10.21873/anticanres.14592. Anticancer Res. 2020. PMID: 32988903 Clinical Trial.
An ultra-stable cytoplasmic antibody engineered for in vivo applications.
Kabayama H, Takeuchi M, Tokushige N, Muramatsu SI, Kabayama M, Fukuda M, Yamada Y, Mikoshiba K. Kabayama H, et al. Among authors: yamada y. Nat Commun. 2020 Jan 17;11(1):336. doi: 10.1038/s41467-019-13654-9. Nat Commun. 2020. PMID: 31953402 Free PMC article.
8,288 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page